105 related articles for article (PubMed ID: 12450740)
1. Effect of intraperitoneal mRNA antisense-oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats: association with pre-experimental stress.
Cohen H; Matar MA; Buriakovsky I; Zeev K; Kotler M; Bourin M
Neuropeptides; 2002 Oct; 36(5):341-52. PubMed ID: 12450740
[TBL] [Abstract][Full Text] [Related]
2. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein.
Cohen H
Depress Anxiety; 2005; 22(2):84-93. PubMed ID: 16149040
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of anxiety in rats by antisense to cholecystokinin precursor protein.
Cohen H; Kaplan Z; Kotler M
Biol Psychiatry; 1998 Nov; 44(9):915-7. PubMed ID: 9807648
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.
Torner L; Toschi N; Pohlinger A; Landgraf R; Neumann ID
J Neurosci; 2001 May; 21(9):3207-14. PubMed ID: 11312305
[TBL] [Abstract][Full Text] [Related]
7. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
[TBL] [Abstract][Full Text] [Related]
8. Intervention mechanism of repeated oral GABA administration on anxiety-like behaviors induced by emotional stress in rats.
He Y; Ouyang J; Hu Z; Yang J; Chu Y; Huang S; Yang Y; Liu C
Psychiatry Res; 2019 Jan; 271():649-657. PubMed ID: 30791338
[TBL] [Abstract][Full Text] [Related]
9. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois JM
Psychopharmacology (Berl); 2000 Feb; 148(2):153-63. PubMed ID: 10663430
[TBL] [Abstract][Full Text] [Related]
10. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of cholecystokinin (CCK-8) microinjection into the ventrolateral and dorsolateral periaqueductal gray on anxiety models in Wistar rats.
Vázquez-León P; Campos-Rodríguez C; Gonzalez-Pliego C; Miranda-Páez A
Horm Behav; 2018 Nov; 106():105-111. PubMed ID: 30342011
[TBL] [Abstract][Full Text] [Related]
12. Protective and therapeutic effects of glyprolines in psychoemotional stress induced by cholecystokinin-4 injection.
Edeeva SE; Kopylova GN; Bakaeva ZV; Samona GE; Umarova BA; Guseva AA
Bull Exp Biol Med; 2008 Mar; 145(3):302-6. PubMed ID: 19039929
[TBL] [Abstract][Full Text] [Related]
13. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
Adamec R; Strasser K; Blundell J; Burton P; McKay DW
Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.
Ballaz SJ; Bourin M; Akil H; Watson SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109761. PubMed ID: 31526831
[TBL] [Abstract][Full Text] [Related]
15. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
[TBL] [Abstract][Full Text] [Related]
16. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
17. CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder.
Cohen H; Kaplan Z; Kotler M
Depress Anxiety; 1999; 10(1):8-17. PubMed ID: 10499184
[No Abstract] [Full Text] [Related]
18. Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.
Zhang Z; Morse AC; Koob GF; Schulteis G
Alcohol Clin Exp Res; 2007 Nov; 31(11):1811-9. PubMed ID: 17877783
[TBL] [Abstract][Full Text] [Related]
19. The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects.
Staples LG; Cornish JL
Horm Behav; 2014 Mar; 65(3):294-300. PubMed ID: 24397997
[TBL] [Abstract][Full Text] [Related]
20. Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115.
Kolik LG; Gudasheva TA; Seredenin SB
Bull Exp Biol Med; 2012 Oct; 153(6):851-4. PubMed ID: 23113301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
